Skip to main content
. 2019 Sep 19;8(2):167–174. doi: 10.1177/2050640619878974

Figure 1.

Figure 1.

(a) Terminal ileum thickness was significantly higher in patients with adalimumab trough level (TL) below, rather than above 3 μg/ml. (b) Colonic maximal thickness was significantly higher in patients with adalimumab TL below, rather than above 3 μg/ml.